Research work · 2017

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

Johnny Duerinck, Stephanie Du Four, Frank Bouttens, C. Andre, Vincent Verschaeve, Frank Van Fraeyenhove, C. Chaskis, Nicky D’Haene, Marie Le Mercier, Anne Rogiers, Alex Michotte, Isabelle J. Salmon, Bart Neyns

Journal of Neuro-Oncology

DOI: 10.1007/s11060-017-2629-z